InterMune reiterated at market perform by JMP

JMP Securities analyst Adam Cutler reiterated InterMune Inc. at market perform. The company reported fourth-quarter 2005 loss per share of $0.43 from continuing operations compared to the analyst's estimate of a $0.59 loss and the Street's estimate of a $0.66 loss. While the analyst sees potential value in InterMune's pipeline, there is a lack of stock-moving events expected in the next six to nine months. Shares of the Brisbane, Calif., pharmaceutical company were down $2.54, or 12.32%, at $18.07 on volume of 2,927,289 shares versus the three-month running average of 491,136 shares. (Nasdaq: ITMN)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.